| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |